PCPC, CHPA Urge Stretching Sunscreen Ingredient Safety Data Net
This article was originally published in The Rose Sheet
Executive Summary
PCPC and CHPA submit comments to FDA on Sunscreen Innovation Act compliance draft guidances. The groups ask the agency to expand the categories of data sufficient to support sunscreen ingredients as GRASE and suggest augmenting NDAC deliberations with input from toxicologists and biologists.
You may also be interested in...
FDA Drafts Guidance On Safety-Data Musts For GRASE Sunscreen Actives
Time and extent applicants seeking GRASE status for UV filters should provide FDA with the kind of clinical safety data used to support approval of chronic-use cutaneous drug products, and nonclinical testing should focus on potential long-term adverse effects, according to newly released draft guidance required from the agency under the Sunscreen Innovation Act. FDA is particularly interested in receiving comments about final formulation safety testing it anticipates requiring under specified monograph conditions.
IFF Narrows Focus To Fragrance, Health, Food
International Flavors & Fragrances agrees to sell its Pharma Solutions business to plant-based ingredients company Roquette for an enterprise value of $2.85bn to reduce debt and streamline its business to three segments, including scents.
MoCRA Implementation In US Election Year: Q&A With Attorney Wade Ackerman
Wade Ackerman, partner at Covington & Burling who served previously as senior FDA counsel to US Senate Health Education, Labor & Pensions (HELP) Committee leadership, discusses expectations for FDA activity under modernized cosmetics regulations in 2024.